PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

Similar documents
How to write ADaM specifications like a ninja.

Why organizations need MDR system to manage clinical metadata?

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

CDISC Standards End-to-End: Enabling QbD in Data Management Sam Hume

How to review a CRF - A statistical programmer perspective

PharmaSUG Paper PO22

Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata

Pharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data

An Efficient Solution to Efficacy ADaM Design and Implementation

Programming checks: Reviewing the overall quality of the deliverables without parallel programming

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008

Standards Driven Innovation

ODM The Operational Efficiency Model: Using ODM to Deliver Proven Cost and Time Savings in Study Set-up

How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation

Advantages of a real end-to-end approach with CDISC standards

Best Practices for E2E DB build process and Efficiency on CDASH to SDTM data Tao Yang, FMD K&L, Nanjing, China

Lex Jansen Octagon Research Solutions, Inc.

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Paper DS07 PhUSE 2017 CDISC Transport Standards - A Glance. Giri Balasubramanian, PRA Health Sciences Edwin Ponraj Thangarajan, PRA Health Sciences

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

Now let s take a look

Automated Creation of Submission-Ready Artifacts Silas McKee, Accenture, Pennsylvania, USA Lourdes Devenney, Accenture, Pennsylvania, USA

An Alternate Way to Create the Standard SDTM Domains

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method

Material covered in the Dec 2014 FDA Binding Guidances

Traceability Look for the source of your analysis results

PhUSE EU Connect Paper PP15. Stop Copying CDISC Standards. Craig Parry, SyneQuaNon, Diss, England

PharmaSUG. companies. This paper. will cover how. processes, a fairly linear. before moving. be carried out. Lifecycle. established.

Clinical Metadata Metadata management with a CDISC mindset

Taming Rave: How to control data collection standards?

From ODM to SDTM: An End-to-End Approach Applied to Phase I Clinical Trials

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

Implementing CDISC Using SAS. Full book available for purchase here.

From raw data to submission: A metadata-driven, repository-based process of data conversion to CDISC models

How to handle different versions of SDTM & DEFINE generation in a Single Study?

SAS offers technology to facilitate working with CDISC standards : the metadata perspective.

CDISC SDTM and ADaM Real World Issues

Creating an ADaM Data Set for Correlation Analyses

Automation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China

Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

PharmaSUG Paper DS16

Out-of-the-box %definexml

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS

CDISC Standards and the Semantic Web

Managing your metadata efficiently - a structured way to organise and frontload your analysis and submission data

Dataset-XML - A New CDISC Standard

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE

One Project, Two Teams: The Unblind Leading the Blind

Creating a Patient Profile using CDISC SDTM Marc Desgrousilliers, Clinovo, Sunnyvale, CA Romain Miralles, Clinovo, Sunnyvale, CA

Harnessing the Web to Streamline Statistical Programming Processes

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission

Customer oriented CDISC implementation

CDISC Variable Mapping and Control Terminology Implementation Made Easy

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES

PharmaSUG Paper PO21

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India

Aquila's Lunch And Learn CDISC The FDA Data Standard. Disclosure Note 1/17/2014. Host: Josh Boutwell, MBA, RAC CEO Aquila Solutions, LLC

PharmaSUG Paper PO10

PharmaSUG Paper DS24

DIA 11234: CDER Data Standards Common Issues Document webinar questions

CDISC Public Webinar Standards Updates and Additions. 26 Feb 2015

Metadata and ADaM.

Applying ADaM Principles in Developing a Response Analysis Dataset

Lex Jansen Octagon Research Solutions, Inc.

Introduction to ADaM and What s new in ADaM

Standards Implementation: It Should be Simple Right? Thursday January 18, 2018

PharmaSUG Paper CC02

Standards Metadata Management (System)

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

PhUSE Paper SD09. "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

From SDTM to displays, through ADaM & Analyses Results Metadata, a flight on board METADATA Airlines

Optimization of the traceability when applying an ADaM Parallel Conversion Method

Easy CSR In-Text Table Automation, Oh My

What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting

esubmission - Are you really Compliant?

The Submission Data File System Automating the Creation of CDISC SDTM and ADaM Datasets

SDTM Automation with Standard CRF Pages Taylor Markway, SCRI Development Innovations, Carrboro, NC

Streamline SDTM Development and QC

esource Initiative ISSUES RELATED TO NON-CRF DATA PRACTICES

BUSINESS-BASED VALUE IN AN MDR

START CONVERTING FROM TEXT DATE/TIME VALUES

Codelists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California

PharmaSUG2014 Paper DS09

Converting Data to the SDTM Standard Using SAS Data Integration Studio

Introduction to Define.xml

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

SAS Clinical Data Integration 2.4

A SDTM Legacy Data Conversion

Legacy to SDTM Conversion Workshop: Tools and Techniques

PhUSE US Connect 2019

Transcription:

ABSTRACT PharmaSUG 2014 PO16 Automation of ADAM set Creation with a Retrospective, Prospective and Pragmatic Process Karin LaPann, MSIS, PRA International, USA Terek Peterson, MBA, PRA International, USA In the CDISC Standards, analysis datasets (ADaM) hold a unique place in the end to end process and must be created with both a prospective and retrospective view of the entire clinical trial process. Analysis datasets must support the statistical analysis plan (SAP) by providing accurate efficacy and safety analyses. Companies must be pragmatic in deciding which processes can be automated by tools. Industry has tools to effectively transform data to the SDTM structure. These tools should be able build a large portion of the appropriate ADaM datasets with maximum efficiency. The burning question: Can ADaM datasets be built with a mapping tool just like SDTM? INTRODUCTION The theme of this paper is to describe how standards can aid in the process of automating analysis datasets, to give programmers and biostatistician more time to focus on the science and unique analyses for new novel indications and treatments. Automated processes require the proper governance by sponsors internally, and through collaboration between Clinical Research Organizations and the Sponsors. The decisions made interpreting the standards need to be collected and documented using a Meta Repository (MDR) so that rigorous and consistent implementation can be assured. The MDR can provide consistent input to the processing of the data from collection to Tables, Figures and Listings (TFL s) which then are used by medical writers to create the Clinical Study Report (CSR). Although the CDISC standards have evolved greatly, there is still a lot of room for interpretation by users of these standards. Below is a table reviewing the standards. Differentiating the CDISC Standards Category CDASH SDTM ADaM Purpose Collection of data from ecrf in a consistent manner Submission in standardized tabular form Analysis data for use in Tables, Listings and Figures Structure Flexible Rigid Flexible * Part of Submission package No Yes Yes Output(s) CRF collection data in electronic form Transformed data from collection into SDTM tabular format in electronic form. Copied data from SDTM for traceability. Derived data as per derivations from SAP. * In order to automate, must decide on standard structure within set of studies. Large Pharmaceuticals often have legacy tabulation standards which they then must update to SDTM. Often they hire Clinical Research Organizations (CRO s) to handle this conversion process. The ADaM portion, being newer in 1

Automation of ADaM set Creation with a Retrospective, Prospective and Pragmatic Process, continued acceptance, has more flexibility and standards are in the process broadened and improved based on industry usage.. Raw collection to SDTM is handled by many CRO s with in-house mapping tools. These tools, along with machine readable metadata, can be used with a MDR to automate the process of SDTM and ADaM dataset creation. This process must be exact in its interpretations of standards from the various CDISC documents, the collected data and the sponsor interpretations of the standards (in this case the pharmaceutical company sponsoring the study). ADaM datasets also are candidates for automation, as long as the metadata is collected and stored in machinereadable form. The data comes not only from the SDTM domains which are the building blocks of the Analysis sets, but also from the final product which are the Tables, Figures and Listings mocks/shells providing the supporting analyses for the Statistical Analysis Plan. These must be annotated and documented so that a retrospective process can begin. ADaM is therefore the missing link between SDTM and TFL s. RETROSPECTIVE PROCESS ret ro spec tive adj. 1. Looking back on, contemplating, or directed to the past. 2. Looking or directed backward. 3. Applying to or influencing the past; retroactive. First and foremost, the analysis datasets must support the statistical analysis plan (SAP) by providing accurate efficacy and safety analyses. Part of the SAP is a set of mock tables. These can be annotated just like an ecrf with the ADaM-compliant variable names so that these can be derived or pulled in from the original collected data. This process is also being standardized by work groups within various organizations such as PhUse in developing standard analysis scripts by therapeutic area. These scripts intend to provide guidance on recommended Tables, Figures and Listings that are part of standard clinical submissions. The retrospective process is described by the picture below. Traditionally, the ADaM datasets have been considered to be derived from the SDTM. The newer thinking is look through the Biostatistician s viewpoint and to look backwards from the end goal. The Biostatistician has input at the beginning as to what is collected as described in the protocol. Then the focus goes into the SAP, where the tables are mocked up and final hypotheses will be tested. A Linear Approach to Standards CDASH (EDC, CRF, Vendor ) SDTM ADaM Appendix of Clincal Study Report (TFLs) How we Should be Approaching the Standards Appendix of Clincal Study Report (TFLs) ADaM SDTM CDASH (EDC, CRF, Vendor ) Building the MDR required for this approach includes the involvement of all the stakeholders along the process. Having the end in mind requires an integrated team approach from the following groups: Electronic Capture team (EDC) management (DM) Clinical Programming (CP) Biostatistics (Stats) 2

Automation of ADaM set Creation with a Retrospective, Prospective and Pragmatic Process, continued One of the ADaM premises, to be one proc or step away from creating the tables and listings plays on this theme. Only by working backwards and literally annotating the table with the required fields can we be sure to collect what is needed up front. Metadata management is essential to automation. In the flowchart to the right we show various MDR stores that contribute to the automated process and reduce the amount of manual interaction to the key analyses and individualized endpoints that should always be a part of a scientific exploration. In order for the process described to work we need the functional areas along the way to continuously ensure that standards are being adhered to and metadata is passed from one step to the next. Below is the big picture of the possibility with input and metadata: PROSPECTIVE PROCESS pro spec tive adj. 1. Likely or expected to happen. 2. Likely to become or be CDISC standards are the first component in the metadata build. These are available in machine readable form and read into the CRO/Sponsor Global Metadata Repository (GMDR). Any interpretations for individual custom forms, domains, and ADaM datasets are added to the GMDR. Since CDASH standards offer some flexibility, the Sponsor must have their interpretations clearly described in the metadata that is stored in the GMDR. in the above model can be accessed at all levels of processing, whether it is at the collection point, the data reviewing by data management teams, or by programs that process and push the data to the next data store. Machine consumable metadata in the form of detailed specifications, control terminology and requirements forms the basis of automation. Further automation is possible through ODM. In the future through ODM, we should be able to 3

Automation of ADaM set Creation with a Retrospective, Prospective and Pragmatic Process, continued automatically push additional data from CDASH to SDTM to ADaM. See example below. (here we collect time, although not usually collected unless a pediatric study). CDASH DM101 ------------------------- BRTHDY (DD) BRTHMO (MM) BRTHYR (YY) BRTHTIM (HH:MM) SDTM - DM ----------------------------------------- BRTHDTC (YYYY-MM-DDTHH:MM) ADaM ADSL ------------------------ BRTHDT BRTHTM BRTHDTM Character Character Numeric When the system sees these fields in CDASH ending in DY, MO, YR and TIM it can then appropriately push the data to SDTM ISO8601 format, and to ADaM numeric format as per information stored in the GMDR on all these types of fields. Due to standardization of naming conventions, the process is further automated for potential new date elements. The character date kept for traceability from SDTM to ADaM. PRAGMATIC prag ma tic adj. 1. Dealing or concerned with facts or actual occurrences; practical. 2. Philosophy of or relating to pragmatism. The third element is a pragmatic one, where one decides what portion of the process can be automated by tools. This part requires extensive governance by the sponsor and the CRO. It needs: company-wide standards implementation Sponsorship Standard content alone is not a solution without a tool or tools Jointly living the vision An example of an actual implementation is given below. The tool below shows how SDTM and ADaM creation are being automated. 4

Automation of ADaM set Creation with a Retrospective, Prospective and Pragmatic Process, continued Example of Mapping by using an GMDR and SMDR to build SDTM Domains Example of Implementing Standard Derivations to ADaM The above two slides show a real live implementation of a tool built to take advantage of standards to facilitate mapping and conversion efforts. The idea of metadata driven systems is becoming more and more a reality, across both individual companies and also at CDISC with the current development of the SHARE metadata repository. CONCLUSION To automate the creation of ADaM datasets no single approach will get the desired result. A retrospective, 5

Automation of ADaM set Creation with a Retrospective, Prospective and Pragmatic Process, continued prospective, and pragmatic process must be used to automate the creation of ADaM datasets. ADaM datasets are the keys between SDTM domains and TFLs, which must support the statistical analysis plan by providing accurate efficacy and safety analyses. Retrospectively, keeping the end in mind from the beginning with an integrated team approach will better influence systems earlier during data collection and SDTM conversion. For this to work, solid draft SAPs including annotated TFL shells must be completed before EDC systems are built. Strict adherence to CDASH and SDTM interpretations sets the building blocks for ADaM automation. Prospectively for the process to be automated we need to produce machine consumable metadata in the form of an MDR and other tools that are able to push metadata form one standard to the other in a linear process. The use of ODM XML does have features that allow for information system interoperability so that hardware devices and software routines work harmoniously together. Organizations must be pragmatic in not taking on too much at one time. For success, clear commitment and sponsorship from the leadership in the company is essential with funding for tool implementation and governance. Single groups cannot work in siloes; it takes company-wide standards implementation with longevity and perseverance over potentially many years to get to the point of automation. By adhering to the standards developed by the CDISC organization, we can get closer to the goal of automating as much of the process as possible, giving programmers and biostatisticians more time to focus on the science and unique analyses for new novel indications and treatments. REFERENCES www.phuse.eu www.cdisc.org ACKNOWLEDGMENTS The authors would like to thank PRA International for participating in the PhUSE initiatives in 2013. CONTACT INFORMATION Your comments and questions are valued and encouraged. Contact the authors at: Name: Karin LaPann Title: Principal CDISC Standards Consultant Enterprise: PRA International Address: 630 Dresher Road City, State ZIP: Horsham, PA 19044 Work Phone: 860-4348613 E-mail: LaPannKarin@PRAIntl.com Web: www.praintl.com Name: Terek Peterson, MBA Title: Senior Director, Global Standards Strategies Enterprise: PRA International Address: 630 Dresher Road City, State ZIP: Horsham, PA 19044 Work Phone: 215-444-8613 E-mail: PetersonTerek@PRAIntl.com Web: www.praintl.com SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. indicates USA registration. Other brand and product names are trademarks of their respective companies. 6